Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001897612-25-000087·AVANOS MEDICAL, INC.
Schedule 13G ownership disclosure
AVANOS MEDICAL, INC.
COMMON STOCK · CUSIP: 05350V106
Event date: 2024-12-31
- Filing-level shares
- 3,011,312
- Percent of class
- 6.6%
- T. Rowe Price Investment Management, Inc.
Shares: 3,011,312 · Class: 6.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-25-000087
- Form type
- SCHEDULE 13G/A
- Filer
- AVANOS MEDICAL, INC.
- CIK
- CIK 1606498
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership